全文获取类型
收费全文 | 12198篇 |
免费 | 888篇 |
国内免费 | 37篇 |
专业分类
耳鼻咽喉 | 133篇 |
儿科学 | 330篇 |
妇产科学 | 257篇 |
基础医学 | 1854篇 |
口腔科学 | 157篇 |
临床医学 | 1031篇 |
内科学 | 2508篇 |
皮肤病学 | 238篇 |
神经病学 | 1146篇 |
特种医学 | 657篇 |
外国民族医学 | 2篇 |
外科学 | 1936篇 |
综合类 | 116篇 |
一般理论 | 4篇 |
预防医学 | 989篇 |
眼科学 | 174篇 |
药学 | 644篇 |
中国医学 | 44篇 |
肿瘤学 | 903篇 |
出版年
2023年 | 86篇 |
2022年 | 120篇 |
2021年 | 264篇 |
2020年 | 182篇 |
2019年 | 260篇 |
2018年 | 303篇 |
2017年 | 227篇 |
2016年 | 270篇 |
2015年 | 309篇 |
2014年 | 377篇 |
2013年 | 493篇 |
2012年 | 814篇 |
2011年 | 816篇 |
2010年 | 486篇 |
2009年 | 495篇 |
2008年 | 741篇 |
2007年 | 745篇 |
2006年 | 714篇 |
2005年 | 685篇 |
2004年 | 658篇 |
2003年 | 586篇 |
2002年 | 570篇 |
2001年 | 247篇 |
2000年 | 234篇 |
1999年 | 195篇 |
1998年 | 142篇 |
1997年 | 124篇 |
1996年 | 97篇 |
1995年 | 115篇 |
1994年 | 74篇 |
1993年 | 81篇 |
1992年 | 98篇 |
1991年 | 96篇 |
1990年 | 109篇 |
1989年 | 93篇 |
1988年 | 72篇 |
1987年 | 84篇 |
1986年 | 85篇 |
1985年 | 89篇 |
1984年 | 68篇 |
1983年 | 70篇 |
1982年 | 46篇 |
1981年 | 45篇 |
1980年 | 47篇 |
1979年 | 52篇 |
1978年 | 40篇 |
1974年 | 46篇 |
1973年 | 40篇 |
1971年 | 33篇 |
1969年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Cromb Amandine Le Loarer Franois Sitbon Maxime Italiano Antoine Stoeckle Eberhard Buy Xavier Kind Michle 《European radiology》2020,30(5):2413-2424
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification... 相似文献
2.
3.
4.
5.
6.
7.
8.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
9.
10.
Gil Bolotin Frederik H. van der Veen Roberto Lorusso Tamir Wolf Robert Sachner Rona Shofti Jan J. Shreuder Gideon Uretzky 《European journal of cardio-thoracic surgery》2002,21(6):975-980
Objective: Descending and ascending aortomyoplasty are two surgical procedures intended to induce hemodynamic benefits similar to those of the intra-aortic-balloon-pump (IABP). To date, there have been no studies comparing the two surgical techniques. The objective of this study was to compare coronary blood flow augmentation and afterload reduction as produced by descending and ascending aortomyoplasty counterpulsation Methods: Twenty-two mongrel dogs (18–35 kg) underwent IABP application (n=7), descending (n=8), or ascending (n=7) aortomyoplasty. Left anterior descending (LAD) coronary artery blood flow was measured using a Transonic Doppler flow probe. Left ventricular pressure as well as aortic pressures proximal and distal to either the aortomyoplasty site or the IABP position were monitored continuously. Results: Descending aortomyoplasty induced higher elevation in the LAD blood flow during assisted beats (27% from 10.8±4 to 13.8±6 ml/min, P<0.001) than that induced by either ascending aortomyoplasty (19% from 11.7±5 to 14±5 ml/min, P<0.001) or IABP counterpulsation (18% from 8.6±3 to 10.2±4 ml/min, P<0.001). Conversely, while ascending aortomyoplasty reduced the left ventricular end-diastolic pressure by 16% (from 60±18 to 50±22 mmHg, P<0.001), similar to the 16% after load reduction achieved by the IABP counterpulsation, descending aortomyoplasty failed to induce afterload reduction. Conclusions: Descending aortomyoplasty produces higher coronary blood flow augmentation than either ascending aortomyoplasty or IABP. However, afterload reduction comparable to that achieved by IABP was observed only with ascending aortomyoplasty and not with descending aortomyoplasty. 相似文献